Tandem Diabetes Care share price today

(TNDM)

Tandem Diabetes Care share price is $35.91 & ₹3,051.49 as on 21 Dec 2024, 2.30 'hrs' IST

$35.91

▲

2.64

(7.94%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Tandem Diabetes Care share price in Dollar and Rupees. Guide to invest in Tandem Diabetes Care from India. Also see the sentimental analysis on Indian investors investing in Tandem Diabetes Care. Get details on the Indian mutual funds that are investing in Tandem Diabetes Care. Get Analyst recommendations and forecasts along with all the Tandem Diabetes Care's financials.

Tandem Diabetes Care share price movements

Today's Low: $32.46
Today's High: $36.30
$35.91
9.61%
Downside
Day's Volatility :10.58%
Upside
1.07%
52 Weeks Low: $21.85
52 Weeks High: $53.69
$35.91
39.15%
Downside
52 Weeks Volatility :59.3%
Upside
33.12%

Tandem Diabetes Care Returns

Period	Tandem Diabetes Care, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-26.75%	-12.2%	0.0%
6 Months	-16.78%	-6.9%	0.0%
1 Year	12.82%	2.7%	0.0%
3 Years	-78.23%	-0.2%	-17.3%

Tandem Diabetes Care Key Statistics

in dollars & INR

Previous Close	$33.27
Open	$32.66
Today's High	$36.3
Today's Low	$32.46
Market Capitalization	$2.2B
Today's Volume	$855.4K
52 Week High	$53.69
52 Week Low	$21.85
Revenue TTM	$854.4M
EBITDA	$-130.7M
Earnings Per Share (EPS)	$-1.94
Profit Margin	-14.84%
Quarterly Earnings Growth YOY	-0.37%
Return On Equity TTM	-45.96%

How to invest in Tandem Diabetes Care from India?

It is very easy for Indian residents to invest directly in Tandem Diabetes Care from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Tandem Diabetes Care stock in both Indian Rupees (INR) and US Dollars (USD). Search for Tandem Diabetes Care or TNDM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Tandem Diabetes Care or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Tandem Diabetes Care shares which would translate to 0.024 fractional shares of Tandem Diabetes Care as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Tandem Diabetes Care, in just a few clicks!

Returns in Tandem Diabetes Care for Indian investors in Rupees

Investment Value

₹1,00,000

Tandem Diabetes Care investment value today

Current value as on today

₹1,23,865

Returns

₹23,865

(+23.87%)

Returns from Tandem Diabetes Care Stock

₹21,770 (+21.77%)

Dollar Returns

₹2,095 (+2.1%)

Indian investors sentiment towards Tandem Diabetes Care

40%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Tandem Diabetes Care on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 40% more investors are searching Tandem Diabetes Care in the last 30 days versus the previous period.

Global Institutional Holdings in Tandem Diabetes Care

BlackRock Inc
16.94%
Vanguard Group Inc
11.21%
Capital World Investors
4.97%
State Street Corp
4.04%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)
3.63%
Fred Alger Management, LLC
3.01%

Analyst Recommendation on Tandem Diabetes Care

Buy

65%Buy

30%Hold

4%Sell

Based on 23 Wall street analysts offering stock ratings for Tandem Diabetes Care(by analysts ranked 0 to 5 stars)

Based on 23 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Tandem Diabetes Care

What analysts predicted

Upside of 42.02%

Current:

$35.91

Target:

$51.00

Insights on Tandem Diabetes Care

Price Movement
In the last 7 days, TNDM stock has moved up by 1.9%
Increasing Revenue
Revenue is up for the last 3 quarters, 191.67M → 363.28M (in $), with an average increase of 26.3% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -42.71M → -23.25M (in $), with an average increase of 35.6% per quarter
TNDM vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 61.3% return, outperforming this stock by 40.5%
TNDM vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 124.5% return, outperforming this stock by 201.7%
Price to Sales
ForTNDM every $1 of sales, investors are willing to pay $2.5, whereas for Boston Scientific Corp., the investors are paying $8.2 for every $1 of sales.

Tandem Diabetes Care Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$183.9M	↑ 70.88%
Net Income	$-122.6M	↑ 67.88%
Net Profit Margin	-66.68%	↑ 1.19%

	FY19	Y/Y Change
Revenue	$362.3M	↑ 97.05%
Net Income	$-24.8M	↓ 79.81%
Net Profit Margin	-6.83%	↑ 59.85%

	FY20	Y/Y Change
Revenue	$498.8M	↑ 37.68%
Net Income	$-34.4M	↑ 38.9%
Net Profit Margin	-6.89%	↓ 0.06%

	FY21	Y/Y Change
Revenue	$702.8M	↑ 40.89%
Net Income	$15.6M	↓ 145.27%
Net Profit Margin	2.21%	↑ 9.1%

	FY22	Y/Y Change
Revenue	$801.2M	↑ 14.0%
Net Income	$-94.6M	↓ 707.7%
Net Profit Margin	-11.81%	↓ 14.02%

	FY23	Y/Y Change
Revenue	$747.7M	↓ 6.68%
Net Income	$-222.6M	↑ 135.33%
Net Profit Margin	-29.77%	↓ 17.96%

	Q2 FY23	Q/Q Change
Revenue	$195.9M	↑ 15.67%
Net Income	$-35.8M	↓ 71.12%
Net Profit Margin	-18.26%	↑ 54.87%

	Q3 FY23	Q/Q Change
Revenue	$185.6M	↓ 5.25%
Net Income	$-33.0M	↓ 7.87%
Net Profit Margin	-17.76%	↑ 0.5%

	Q4 FY23	Q/Q Change
Revenue	$196.8M	↑ 6.02%
Net Income	$-30.0M	↓ 8.98%
Net Profit Margin	-15.25%	↑ 2.51%

	Q1 FY24	Q/Q Change
Revenue	$191.7M	↓ 2.6%
Net Income	$-42.7M	↑ 42.37%
Net Profit Margin	-22.29%	↓ 7.04%

	Q2 FY24	Q/Q Change
Revenue	$221.9M	↑ 15.77%
Net Income	$-30.8M	↓ 27.86%
Net Profit Margin	-13.89%	↑ 8.4%

	Q3 FY24	Q/Q Change
Revenue	$363.3M	↑ 63.71%
Net Income	$-23.3M	↓ 24.54%
Net Profit Margin	-6.4%	↑ 7.49%

	FY18	Y/Y Change
Profit	$89.8M	↑ 103.71%

	FY19	Y/Y Change
Profit	$194.2M	↑ 116.22%

	FY20	Y/Y Change
Profit	$260.5M	↑ 34.14%

	FY21	Y/Y Change
Profit	$376.2M	↑ 44.41%

	FY22	Y/Y Change
Profit	$413.0M	↑ 9.77%

	FY23	Y/Y Change
Profit	$367.7M	↓ 10.97%

	Q2 FY23	Q/Q Change
Profit	$101.7M	↑ 22.71%

	Q3 FY23	Q/Q Change
Profit	$89.8M	↓ 11.78%

	Q4 FY23	Q/Q Change
Profit	$93.3M	↑ 3.95%

	Q1 FY24	Q/Q Change
Profit	$94.7M	↑ 1.48%

	Q2 FY24	Q/Q Change
Profit	$112.8M	↑ 19.14%

	Q3 FY24	Q/Q Change
Profit	$124.7M	↑ 10.51%

	FY18	Y/Y Change
Operating Cash Flow	$-8.3M	↓ 87.42%
Investing Cash Flow	$-90.7M	↓ 3361.65%
Financing Cash Flow	$117.2M	↑ 261.95%

	FY19	Y/Y Change
Operating Cash Flow	$41.9M	↓ 603.73%
Investing Cash Flow	$-57.0M	↓ 37.23%
Financing Cash Flow	$24.2M	↓ 79.34%

	FY20	Y/Y Change
Operating Cash Flow	$24.7M	↓ 41.13%
Investing Cash Flow	$-296.1M	↑ 419.81%
Financing Cash Flow	$314.4M	↑ 1198.95%

	FY21	Y/Y Change
Operating Cash Flow	$111.4M	↑ 351.41%
Investing Cash Flow	$-186.9M	↓ 36.88%
Financing Cash Flow	$51.9M	↓ 83.48%

	FY22	Y/Y Change
Operating Cash Flow	$50.5M	↓ 54.68%
Investing Cash Flow	$33.2M	↓ 117.75%
Financing Cash Flow	$16.9M	↓ 67.5%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-6.3M	↓ 65.5%
Investing Cash Flow	$5.7M	↓ 121.64%
Financing Cash Flow	$3.9M	↓ 829.76%

Tandem Diabetes Care Technicals Summary

Sell

Neutral

Buy

Tandem Diabetes Care is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Tandem Diabetes Care Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Tandem Diabetes Care, Inc.	10.35%	-16.78%	12.82%	-78.23%	-45.2%
Stryker Corporation	-7.4%	5.33%	20.05%	35.25%	68.03%
Boston Scientific Corp.	-1.67%	15.58%	58.6%	110.29%	96.06%
Edwards Lifesciences Corp.	6.31%	-18.01%	-2.51%	-42.17%	-6.54%
Abbott Laboratories	-3.03%	6.76%	3.11%	-19.12%	28.7%
Medtronic Plc	-4.9%	-1.3%	-2.36%	-21.07%	-29.77%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Tandem Diabetes Care, Inc.	473.44	NA	0.0	-1.72	-0.46	-0.1	NA	3.62
Stryker Corporation	38.46	38.46	2.51	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	72.75	72.75	1.64	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.54	28.54	6.69	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.02	34.02	2.2	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.47	24.47	1.49	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Tandem Diabetes Care, Inc.	Buy	$2.2B	-45.2%	473.44	-14.84%
Stryker Corporation	Buy	$136.9B	68.03%	38.46	16.34%
Boston Scientific Corp.	Buy	$129.7B	96.06%	72.75	11.26%
Edwards Lifesciences Corp.	Buy	$43.6B	-6.54%	28.54	65.86%
Abbott Laboratories	Buy	$194.1B	28.7%	34.02	13.99%
Medtronic Plc	Buy	$102.6B	-29.77%	24.47	12.06%

About Tandem Diabetes Care

tandem diabetes care, inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. the company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. tandem manufactures and sells the t:slim x2™ insulin pump, the only pump capable of remote feature updates using a personal computer, and the t:flex® insulin pump, the first pump designed for people with greater insulin requirements. tandem is based in san diego, california. safety information please note that this account is not intended to be used for product support or medical advice. if you are having a medical emergency, please dial 911. if you are having an issue with one of our products and need immediate assistance, please call our 24 hour customer support team at 877-801-6901 and press 1 twice. tandem insulin pumps are intended for the subcutan

Organization	Tandem Diabetes Care
Employees	2400
CEO	Mr. John F. Sheridan
Industry	Health Technology

Management People of Tandem Diabetes Care

Name	Title
Mr. John F. Sheridan	President, CEO & Director
Ms. Leigh A. Vosseller	Executive VP, CFO & Treasurer
Ms. Susan M. Morrison	Executive VP & Chief Administrative Officer
Mr. David B. Berger Esq.	Transitional Advisor
Ms. Elizabeth Anne Gasser	Executive Vice President and Chief Strategy & Product Officer
Mr. Mark Novara	Executive VP & Chief Commercial Officer
Mr. Jean-Claude E. Kyrillos	Executive VP & COO
Mr. Rick A. Carpenter	Chief Technical Officer
Ms. Shannon M. Hansen J.D.	Executive VP, Chief Legal, Privacy & Compliance Officer and Secretary
Mr. Tom Fox	Chief Human Resources Officer

Important FAQs about investing in Tandem Diabetes Care from India :

What is Tandem Diabetes Care share price today?

Tandem Diabetes Care share price today stands at $35.91, Open: $32.66 ; Previous Close: $33.27 ; High: $36.30 ; Low: $32.46 ; 52 Week High: $53.69 ; 52 Week Low: $21.85. The stock opens at $32.66, after a previous close of $33.27. The stock reached a daily high of $36.30 and a low of $32.46, with a 52-week high of $53.69 and a 52-week low of $21.85.

Can Indians buy Tandem Diabetes Care shares?

Yes, Indians can invest in the Tandem Diabetes Care (TNDM) from India.

With INDmoney, you can buy Tandem Diabetes Care at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Tandem Diabetes Care at zero transaction cost.

How can I buy Tandem Diabetes Care shares from India?

It is very easy to buy Tandem Diabetes Care from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Tandem Diabetes Care be purchased?

Yes, you can buy fractional shares of Tandem Diabetes Care with INDmoney app.

What are the documents required to start investing in Tandem Diabetes Care stocks?

To start investing in Tandem Diabetes Care, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.